Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - USA Compression Partners LP (NYSE: USAC) reported third quarter EPS of $0.13, $0.08 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $240M versus the consensus estimate of $239.97M.
USA Compression Partners LP's stock price closed at $21.67. It is down -1.32% in the last 3 months and down -17.00% in the last 12 months.
USA Compression Partners LP saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See USA Compression Partners LP's stock price’s past reactions to earnings here.
According to InvestingPro, USA Compression Partners LP's Financial Health score is "fair performance".
Check out USA Compression Partners LP's recent earnings performance, and USA Compression Partners LP's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar